SPARC

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical-stage biopharmaceutical company in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic. ...

हिन्दी में

Sun Pharma Advanced Research Company Limited (SPARC) एक क्लिनिकल-स्टेज बायोफार्मास्युटिकल कंपनी है जो हेल्थकेयर सेक्टर, विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक मे...

₹187.74-4.60%1D
Previous trading day close · Data updates after market close
1W: -3.3%
1M: -7.6%
6M: +26.6%
1Y: +42.3%
51/100
Below AvgResearch Score
Market Cap
₹7.3K Cr
Mid Cap
P/E Ratio
3.85
Below avg
P/B Ratio
4.55
Premium
ROE
N/A
ROCE
111.8%
Excellent
Debt / Equity
0.42
Low debt
Div. Yield
N/A
EV/EBITDA
4.27
Attractive
52W Low: ₹108Current: ₹187.7452W High: ₹289
At 44% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
68/100
Growth
Revenue, EPS, profit growth
24/100
Valuation
PE, PB, EV/EBITDA vs sector
72/100
Risk
Debt levels, volatility, coverage
36/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
3.85(Below avg)
Forward P/E
3.39(Attractive)
P/B Ratio
4.55(Premium)
P/S Ratio
3.19(Good)
EV/EBITDA
4.27(Attractive)
Dividend Yield
N/A
5Y CAGR
0.1%(Moderate)
Revenue Growth
314.1%(High)
Profitability
ROE
N/A
ROCE
111.8%(Excellent)
ROA
-80.5%(Average)
Net Margin
83.0%(High)
EBITDA Margin
4073.8%
Financial Health
Debt to Equity
0.42(Low debt)
Current Ratio
0.07(Tight)
Quick Ratio
0.07(Tight)
Interest Coverage
50.16x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
46(Neutral)
RSI Exp (14)
34(Neutral)
MACD
-2.019(Bearish)
MACD Signal
-1.365
BB Position
14%(Lower band)
BB Width
13.34%(Normal)
ADX (14)
10.1(Sideways)
Williams %R
-97.8(Oversold)
MFI (14)
64(Neutral)
CCI (20)
-77(Neutral)
Stoch %K
2(Oversold)
ATR (14)
9.15(Avg True Range)
OBV (M)
308.6(Positive)
1W OBV Chg
-1.1%(Decreasing)
Rel Volume
1.14x(Normal)
Volatility
52.8%(High)
Max DD 1Y
-52.9%(High loss)
Alpha (CAPM)
39.75%(Outperforming Nifty)
Return vs Nifty
45.9%(Beating Nifty)
EMA 200
185.5
EMA 50
201.7
SMA 200
174.6
vs SMA 50
-6.4%(Below SMA50)
vs SMA 200
7.5%(Above SMA200)
Volume
12.70L
Avg Vol 3M
11.1L
Shareholding Pattern
Promoter
65.7%
High confidence
FII
2.5%
DII / MF
0.1%
Share SPARC
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.